{"id":"W2168500832","doi":"10.1016/j.eururo.2014.05.038","title":"Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial","year":2014,"lang":"en","type":"editorial","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Pfizer UK; Institute of Cancer Research; Prostate Cancer UK; Cancer Research UK; Novartis; National Institute for Health and Care Research; Medical Research Council; Sanofi; Janssen Biotech; Astellas European Foundation","keywords":"Enzalutamide; Medicine; Abiraterone; Prednisone; Prostate cancer; Androgen deprivation therapy; Internal medicine; Oncology; Androgen; Urology; Androgen receptor; Cancer; Hormone","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01031775,0.001980611,0.004465668,0.001097672,0.0008900851,0.003873659,0.003018652,0.007368448,0.005659071],"category_scores_gemma":[0.01797038,0.000816386,0.003023061,0.001007112,0.001007107,0.001963069,0.0005250421,0.01472121,0.002718642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002094839,"about_ca_system_score_gemma":0.00321188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001463854,"about_ca_topic_score_gemma":0.004338086,"domain_scores_codex":[0.9965165,0.001323816,0.0005662256,0.0003472097,0.001034809,0.0002114536],"domain_scores_gemma":[0.9881867,0.008168824,0.0007115736,0.0002008332,0.001869822,0.0008623074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002382377,0.00006118641,0.00006892611,0.001878506,0.0004273231,0.0001094321,0.00001299718,0.0001285525,0.000135149,0.0005598218,0.9656906,0.02854511],"study_design_scores_gemma":[0.009958818,0.0009222134,0.001813696,0.003066704,0.003341222,0.0003361774,0.00006494772,0.0009433635,0.0006858578,0.002595089,0.9761552,0.000116713],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0006278739,0.05609856,0.0003782954,0.06806897,0.8697258,0.0001103158,0.000498977,0.0001668546,0.00432439],"genre_scores_gemma":[0.005315245,0.04195081,0.0006682727,0.1037999,0.830965,0.0002102677,0.0003108092,0.0001008225,0.01667879],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01031775,"threshold_uncertainty_score":0.05456614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02257539387822483,"score_gpt":0.2932429138991753,"score_spread":0.2706675200209505,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}